Adial Pharmaceuticals, Inc (ADIL)
Nasdaq: ADIL · Pharmaceutical Preparations · Charlottesville, VA · filing with the SEC since 2011
Who owns Adial Pharmaceuticals, Inc
As filed with the SECHolders of 5% or more
1
Coastlands Capital LP holds 14.2% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Jul 1, 2026 says.
Directors and officers
9
report now, of 14 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Coastlands Capital LP
SCHEDULE 13G/A · filed Jul 1, 2026 · Common Stock, par value $0.001 per share · 9.98% in Jun 24, 2026
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock · reported falling below 5%, from 9.99% in Feb 18, 2026
Mitchell P. Kopin
SCHEDULE 13G · filed Jun 23, 2025 · Common stock, par value $0.001 per share · reported falling below 5%
What ADIL reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Apr 1, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 16 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Coastlands Capital LP | 10% owner | 0 | $0 | 0 | 5 | $100,000 |